Clinical trials: Diabetes Mellitus Poor Control
Poor Glycemic Control, Cardiovascular Risk Factors
The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health
The investigators hypothesise that carnosine supplementation will improve: 1. glycaemic control 2. cardiovascular risk factors 3.
- Conditions
- Poor Glycemic Control, Cardiovascular Risk Factors, Cognitive Function 1, Social
- Trial name
- NCT02917928
- Testing
- carnosine
- Where
- Australia
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Monash University
Type 1 Diabetes
Clinical Utility of Tight Objectives of Advanced Hybrid Closed-loop Systems Among Type 1 Diabetes Patients (TightT1AHCL)
Diabetes is a chronic disease with a relevant public health burden. Maintaining blood glucose levels as close to normal as possible is essential to avoid the associated microvascular and macrovascular complications.
- Trial name
- TightT1AHCL (NCT06466967)
- Testing
- Advanced hybrid closed-loop CamAPS FX
- Where
- Spain
- Volunteers
- 40 people
- Sponsor
- Castilla-La Mancha Health Service
Type 2 Diabetes Mellitus - Poor Control
A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
This study is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of CJC-1134-PC Injection Administered Once Weekly in Antidiabetic Treatment-naive Patients…
- Trial name
- NCT07058545
- Testing
- CJC-1134-PC Injection
- Where
- China
- Volunteers
- 474 people
- Sponsor
- Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
Type 1 Diabetes Mellitus
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
The purpose of this research study is to find out ways to help pre-teens and teens and their families to improve diabetes control and to help with the burden of diabetes management.
- Trial name
- NCT01083433
- Testing
- Diabetes related psychological counseling and education, Continuous Glucose Monitor
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- University Hospitals Cleveland Medical Center
Type 1 Diabetes Mellitus
Continuous Glucose Monitor in Children With Poorly Controlled Diabetes
The purpose of this study is to determine if the use of continuous glucose monitoring in a practical outpatient clinic setting in children with poorly controlled diabetes will lead to improved blood sugar control.
- Trial name
- NCT02530450
- Testing
- continuous glucose monitoring (CGM)
- Volunteers
- 30 people
- Sponsor
- The University of Texas Health Science Center at San Antonio
Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
The goal of this clinical trial is to evaluate the Efficacy and Safety of Chiglitazar Added to Patients with type 2 diabetes who do not respond well to metformin combined with insulin glargine.
- Conditions
- Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect, 128 Patients Were Randomly Assigned 1:1, Metformin and Insulin Glargine Combined With Chiglitazar Sodium Tablets 48mg/ Day Group
- Trial name
- NCT06007014
- Testing
- Chiglitazar sodium
- Where
- China
- Volunteers
- 128 people
- Sponsor
- Yanbing Li
Obesity
Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
A double-blinded, randomised, placebo-controlled trial of liraglutide 3.0 mg in patients with poor weight-loss and a suboptimal glucagon-like peptide-1 response following bariatric surgery
- Trial name
- BARIOPTIMISE (NCT03341429)
- Testing
- Liraglutide Pen Injector [Saxenda]
- Where
- United Kingdom
- Volunteers
- 70 people
- Sponsor
- University College, London